Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-28 @ 6:46 PM
Study NCT ID:
NCT01179594
Status:
WITHDRAWN
Last Update Posted:
2017-02-17
First Post:
2010-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2014-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-11
Completion Date Type:
ESTIMATED
First Submit Date:
2010-08-10
First Submit QC Date:
None
Study First Post Date:
2010-08-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-16
Last Update Post Date:
2017-02-17
Last Update Post Date Type:
ACTUAL